A
global survey for the acceptability of electronic cigarettes or vapes as an
effective tool to treat nicotine addiction was carried out by Kenneth Warner, dean
emeritus from the University of Michigan's School of Public Health and his
team. Warner and colleagues published a study in Nature Medicine, observing the
global view of vaping and investigating countries that promote vaping as a
smoking cessation strategy and countries that don't. They found that the
agencies in the United States and Canada acknowledge the potential importance
of e-cigarette use but consider the evidence to recommend e-cigarettes for
smoking cessation insufficient. However, the United Kingdom and New Zealand
show high-level support and promote e-cigarettes as a first-line smoking
cessation treatment option.
Along
with evaluating differences in regulatory activities across countries, the
researchers examined evidence that vaping improves smoking cessation, the
health consequences of e-cigarettes, and the relevance for clinical care.
They
also mentioned that the Food and Drug Administration symbolizes some
e-cigarette brands as appropriate for public health protection, which is the
standard need for marketing approval. The researchers stated, "This move
indirectly points out that the FDA consents that e-cigarettes can assist some
individuals who would otherwise not quit smoking."
Kenneth
Warner stated that "enough evidence supports e-cigarettes' use as a
first-line aid for smoking cessation in adults." Hence smokers and
healthcare professionals must appreciate their potential value.
The authors thus conclude that accepting the promotion of e-cigarettes
as an armamentarium for smoking cessation is crucial.
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article